By SPC News Staff
The FDA approved nusinersen (Spinraza, Biogen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
DECEMBER 27, 2016